Endo Pharmaceuticals (ENDP) Announces Licensing Agreement with Novartis; Revises FY08 Guidance

March 4, 2008 4:37 PM EST Send to a Friend
Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc. (Nasdaq: ENDP) and a market leader in pain ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login